. Cessation of Rho-BMP signaling and expression of neural crest and ESC markers after withdrawal. The resultant HCEC monolayers after withdrawal were investigated for the level of RhoA-GTP by Western blotting (A; using -tubulin as the loading control); for the transcript and protein expression of BMP ligands and receptors by qRT-PCR and Western blot, respectively (B; P > 0.05, n = 4, using -tubulin as the loading control); for the transcript expression of ESC markers (C) and neural crest markers (D) by qRT-PCR; and for double immunostaining to p120 (green) and BrdU (red; E). Error bars indicate ±SEM. Bars, 25 µm. Figure S2 . BrdU labeling in trypsin-EDTA-treated HCECs inhibited by p120-Kaiso siRNAs. Trypsin-EDTA disrupted the hexagonal shape and altered the intercellular expression pattern of p120, -catenin, N-cadherin, and ZO-1 in the HCEC monolayer cultured in SHEM for 1 d (A). The BrdU-labeled nuclei noted in fibroblastic-like cells were significantly reduced by knockdown with p120 siRNA and p120-Kaiso siRNAs, but not scRNA, for 2 d (B; ##, P < 0.01; n = 4). Error bars indicate ±SEM. Bars, 25 µm. Figure S3 . Lack of reprogramming by p120 or p120-Kaiso siRNA knockdown in SHEM. HCEC monolayers received weekly knockdown by p120 siRNA or p120-Kaiso siRNAs starting at 1 wk of culturing in SHEM. Transcript expression of ESC markers (A) and neural crest cell markers (B) was measured by qRT-PCR after 5 wk of culturing when 5 µg/ml Noggin was added for the last week. Error bars indicate ±SEM. 
